Ervi Audina Munthe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ervi Audina Munthe has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ira Humairah
Department of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia
2 shared publications - Siti Khaerunnisa
Department of Physiology and Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
2 shared publications - Arifa Mustika
Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine, Universitas Airlangga, Surabaya 60131, Indonesia
1 shared publication - Aulia Risqi Fatmariza
Faculty of Health Technology and Management, Institut Ilmu Kesehatan Bhakti Wiyata Kediri, East Java, Indonesia
1 shared publication - Danny Meganingdyah Primartati
Fakultas Teknologi dan Manajemen Kesehatan Institut Ilmu Kesehatan Bhakti Wiyata, Kediri, Indonesia
1 shared publication - Galih Indra Permana
Department of Anatomy and Histology, Faculty of Medicine, Universitas Palangka Raya, Central Kalimantan, Indonesia
1 shared publication
Latest Publications
- Open Access
- 16 July 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
Ficus carica as an Antidiabetic Agent: Evidence from a Meta-analysis of In Vivo Studies
Recent evidence indicates that Ficus carica may exert glucose-lowering effects under diabetic conditions. However, reductions generally do not restore blood glucose to normal levels, raising questions about its reliability as an antidiabetic agent. This study aimed to systematically evaluate the glucose-lowering effects of F. carica in experimental diabetes models through meta-analysis, with additional assessments of dosage influence and comparison to glibenclamide. Relevant studies were retrieved from PubMed, Scopus, and Web of Science, including in vivo experiments on diabetic rats reporting blood glucose or insulin outcomes after F. carica intervention. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using meta-analysis based on leaf extract, dosage, and comparator treatment. F. carica leaf extract significantly reduced blood glucose compared to diabetic controls (SMD = –5.92; 95% CI [–8.13, –3.72]; p = .00001). Subgroup analyses demonstrated consistent effects at doses below 500 mg/kg BW (SMD = –8.11; 95% CI [–12.83, –3.39]; p = .0008) and above 400 mg/kg BW (SMD = –4.95; 95% CI [–7.49, –2.40]; p < .0001). Leaf extract showed no superior effect compared to glibenclamide (SMD = 2.10; 95% CI [0.91, 3.29]; p = .0006). A significant effect on insulin levels was observed in leaf extract (SMD = –3.65; 95% CI [–7.12, –0.18]; p = .04), though inconsistent effects were noted across other plant parts. In conclusion, F. carica demonstrates antidiabetic potential by reducing blood glucose in diabetic rats, but effects remain within the prediabetic range and are not superior to glibenclamide. Further research is needed to achieve normoglycemic reduction and consistent insulin effects under diabetic conditions.
- 16 July 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
Open AccessFicus carica as an Antidiabetic Agent: Evidence from a Meta-analysis of In Vivo Studies
Recent evidence indicates that Ficus carica may exert glucose-lowering effects under diabetic conditions. However, reductions generally do not restore blood glucose to normal levels, raising questions about its reliability as an antidiabetic agent. This study aimed to systematically evaluate the glucose-lowering effects of F. carica in experimental diabetes models through meta-analysis, with additional assessments of dosage influence and comparison to glibenclamide. Relevant studies were retrieved from PubMed, Scopus, and Web of Science, including in vivo experiments on diabetic rats reporting blood glucose or insulin outcomes after F. carica intervention. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using meta-analysis based on leaf extract, dosage, and comparator treatment. F. carica leaf extract significantly reduced blood glucose compared to diabetic controls (SMD = –5.92; 95% CI [–8.13, –3.72]; p = .00001). Subgroup analyses demonstrated consistent effects at doses below 500 mg/kg BW (SMD = –8.11; 95% CI [–12.83, –3.39]; p = .0008) and above 400 mg/kg BW (SMD = –4.95; 95% CI [–7.49, –2.40]; p < .0001). Leaf extract showed no superior effect compared to glibenclamide (SMD = 2.10; 95% CI [0.91, 3.29]; p = .0006). A significant effect on insulin levels was observed in leaf extract (SMD = –3.65; 95% CI [–7.12, –0.18]; p = .04), though inconsistent effects were noted across other plant parts. In conclusion, F. carica demonstrates antidiabetic potential by reducing blood glucose in diabetic rats, but effects remain within the prediabetic range and are not superior to glibenclamide. Further research is needed to achieve normoglycemic reduction and consistent insulin effects under diabetic conditions.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 8 (2) , 99-104
Effectiveness of Spatholobus littoralis Hassk Stem Extract in Repairing Islets of Langerhans Damage in a Diabetic Rat Model
Introduction: Hyperglycemia, driven by insulin resistance and beta-cell dysfunction, is a hallmark of diabetes mellitus, a common chronic disease. The pancreatic islets of Langerhans are frequently harmed as a result. Although scientific evidence is limited, Spatholobus littoralis Hassk (SLH) stem extract possesses antihyperglycemic, anti-inflammatory, and antioxidant properties that may protect the pancreas. This study used histological and physicochemical methods to assess the capacity of the SLH stem extract to repair pancreatic islet damage in streptozotocin (STZ)-induced diabetic rats. Methods: A randomized posttest only control group design was conducted on 35 male Wistar rats induced with STZ (35 mg/kgBW, twice at 7-day intervals), then divided into five groups: Healthy control (K1), diabetic control (K2), and treatment groups (P1–P3) receiving SLH stem extract at 150, 300, and 450 mg/kgBW for 21 days. Histological examination of islets of Langerhans was performed using hematoxylin and eosin staining, and the islet area was quantified in ImageJ. Data were analyzed using one-way ANOVA, followed by the least significant difference post hoc test ( P < 0.05). Results: The area of the islets of Langerhans was significantly reduced in the diabetic rat group ( P = 0.001), and their shape was irregular. At all dosages, SLH stem extract treatment produced a notable improvement, with the most significant effect at 150 mg/kgBW ( P = 0.001). Its pH, Brix, and conductivity were consistent with the extract’s reparative action on the pancreas. Conclusions: Islet morphology and area were improved by SLH stem extract, indicating that it may be used as a supplemental treatment for diabetes.
- 1 July 2025
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 8 (2) , 99-104
Open AccessEffectiveness of Spatholobus littoralis Hassk Stem Extract in Repairing Islets of Langerhans Damage in a Diabetic Rat Model
Introduction: Hyperglycemia, driven by insulin resistance and beta-cell dysfunction, is a hallmark of diabetes mellitus, a common chronic disease. The pancreatic islets of Langerhans are frequently harmed as a result. Although scientific evidence is limited, Spatholobus littoralis Hassk (SLH) stem extract possesses antihyperglycemic, anti-inflammatory, and antioxidant properties that may protect the pancreas. This study used histological and physicochemical methods to assess the capacity of the SLH stem extract to repair pancreatic islet damage in streptozotocin (STZ)-induced diabetic rats. Methods: A randomized posttest only control group design was conducted on 35 male Wistar rats induced with STZ (35 mg/kgBW, twice at 7-day intervals), then divided into five groups: Healthy control (K1), diabetic control (K2), and treatment groups (P1–P3) receiving SLH stem extract at 150, 300, and 450 mg/kgBW for 21 days. Histological examination of islets of Langerhans was performed using hematoxylin and eosin staining, and the islet area was quantified in ImageJ. Data were analyzed using one-way ANOVA, followed by the least significant difference post hoc test ( P < 0.05). Results: The area of the islets of Langerhans was significantly reduced in the diabetic rat group ( P = 0.001), and their shape was irregular. At all dosages, SLH stem extract treatment produced a notable improvement, with the most significant effect at 150 mg/kgBW ( P = 0.001). Its pH, Brix, and conductivity were consistent with the extract’s reparative action on the pancreas. Conclusions: Islet morphology and area were improved by SLH stem extract, indicating that it may be used as a supplemental treatment for diabetes.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 8 (1) , 16-23
Effect of Spatholobus littoralis Hassk. Extract on F2-isoprostane Levels as a Marker of Oxidative Stress in Diabetic Rat Models
Introduction: Type 2 diabetes mellitus (T2DM) is a global metabolic disorder affecting 537 million adults, with projections indicating an increase to 783 million by 2045. Oxidative stress, resulting from elevated reactive oxygen species under hyperglycemic conditions, contributes to the pathogenesis of T2DM. Spatholobus littoralis Hassk. (SLH) (bajakah tampala), a traditional herbal plant from Central Kalimantan, contains antioxidant and antidiabetic compounds such as flavonoids, saponins, tannins, and phenols. These compounds delay binding free radicals and stabilize hydroxides that suppress oxidative stress conditions. This study evaluates the effects of SLH stem extract on hepatic F2-isoprostane levels in streptozotocin-induced diabetic rats to assess its potential to reduce oxidative stress. The research employs a true experimental design. Methods: SLH stems were macerated in 96% ethanol. Twelve-week-old male Wistar rats (150–200 g) were acclimatized for 7 days. Diabetes was induced using streptozotocin (35 mg/kg body weight intraperitoneally) and repeated after 7 days. Rats were divided into standard control, negative control, and treatment groups (150, 300, and 450 mg/kg BW extract). Hepatic F2-isoprostane levels were measured using an enzyme-linked immunosorbent assay kit with a microtiter reader at 450 nm. Data were analyzed using Kruskal–Wallis and Mann–Whitney U-tests (SPSS v26), with P < 0.05 considered meaningful. Results: SLH extract showed reduced F2-isoprostane levels (P = 0.000), particularly at 150 mg/kg BW and 450 mg/kg BW, and demonstrated potential in promoting body weight recovery in streptozotocin-induced diabetic rats. Conclusions: SLH stem extract demonstrates potent antioxidant properties, reducing liver oxidative stress and partially improving metabolic recovery in diabetic rats.
- 1 January 2025
- Published by Wolters Kluwer Health in Biomolecular and Health Science Journal
- Vol. 8 (1) , 16-23
Open AccessEffect of Spatholobus littoralis Hassk. Extract on F2-isoprostane Levels as a Marker of Oxidative Stress in Diabetic Rat Models
Introduction: Type 2 diabetes mellitus (T2DM) is a global metabolic disorder affecting 537 million adults, with projections indicating an increase to 783 million by 2045. Oxidative stress, resulting from elevated reactive oxygen species under hyperglycemic conditions, contributes to the pathogenesis of T2DM. Spatholobus littoralis Hassk. (SLH) (bajakah tampala), a traditional herbal plant from Central Kalimantan, contains antioxidant and antidiabetic compounds such as flavonoids, saponins, tannins, and phenols. These compounds delay binding free radicals and stabilize hydroxides that suppress oxidative stress conditions. This study evaluates the effects of SLH stem extract on hepatic F2-isoprostane levels in streptozotocin-induced diabetic rats to assess its potential to reduce oxidative stress. The research employs a true experimental design. Methods: SLH stems were macerated in 96% ethanol. Twelve-week-old male Wistar rats (150–200 g) were acclimatized for 7 days. Diabetes was induced using streptozotocin (35 mg/kg body weight intraperitoneally) and repeated after 7 days. Rats were divided into standard control, negative control, and treatment groups (150, 300, and 450 mg/kg BW extract). Hepatic F2-isoprostane levels were measured using an enzyme-linked immunosorbent assay kit with a microtiter reader at 450 nm. Data were analyzed using Kruskal–Wallis and Mann–Whitney U-tests (SPSS v26), with P < 0.05 considered meaningful. Results: SLH extract showed reduced F2-isoprostane levels (P = 0.000), particularly at 150 mg/kg BW and 450 mg/kg BW, and demonstrated potential in promoting body weight recovery in streptozotocin-induced diabetic rats. Conclusions: SLH stem extract demonstrates potent antioxidant properties, reducing liver oxidative stress and partially improving metabolic recovery in diabetic rats.